title: Clinical and molecular characterization of a combined 17p13.3 microdeletion with partial monosomy 21q21.3 in a 26-year-old man.
abstract: We led a clinical and molecular characterization of a patient with mild mental delay and dysmorphic features initially referred for cytogenetic exploration of an azoospermia. We employed FISH and array CGH techniques for a better definition and refinement of a double chromosome aberration associating a 17p microdeletion with partial monosomy 21q due to 1:3 meiotic segregation of a maternal reciprocal translocation t(17;21)(p13.3;q21.2) revealed after banding analysis. Brain MRI depicted partial callosal and mild diffuse cerebral atrophies, but without expected signs of lissencephaly. The patient's karyotype formula was: 45,XY,der(17)t(17;21)(p13.3;q21.2)mat,-21. FISH study confirmed these rearrangements and array CGH analysis estimated the loss sizes to at least 635 kb on chromosome 17 and to 15.6 Mb on chromosome 21. The absence of lissencephaly and major brain malformations often associated with 17p terminal deletions could be attributed to the retention of PAFAH1B1, YWHAE and CRK genes. Dysmorphic features, moderate mental impairment and minor brain malformations could result from the 21q monosomy and particularly the partial deletion of the APP-SOD1 region. Azoospermia should result from gamete apoptosis induced by a control mechanism triggered in response to chromosome imbalances. Our study provides an additional case for better understanding and delineating both 17p and 21q deletions.
authors.affiliation: Department of Human Cytogenetics, Moleular Genetics and Reproductive Biology, Farhat Hached University Teaching Hospital, Sousse, Tunisia. hanene_hannechi@yahoo.fr
authors.forename: H
authors.initials: H
authors.lastname: Hannachi
authors.forename: S
authors.initials: S
authors.lastname: Mougou-Zerelli
authors.forename: I
authors.initials: I
authors.lastname: BenAbdallah
authors.forename: N
authors.initials: N
authors.lastname: Mama
authors.forename: I
authors.initials: I
authors.lastname: Hamdi
authors.forename: A
authors.initials: A
authors.lastname: Labalme
authors.forename: H
authors.initials: H
authors.lastname: Elghezal
authors.forename: D
authors.initials: D
authors.lastname: Sanlaville
authors.forename: A
authors.initials: A
authors.lastname: Saad
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics* / Q000473:pathology; D000328:Adult; D001284:Atrophy; D001921:Brain / Q000473:pathology; D002872:Chromosome Deletion; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics*; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D019465:Craniofacial Abnormalities / Q000473:pathology; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008607:Intellectual Disability / Q000473:pathology; D007621:Karyotyping; D008297:Male; D014178:Translocation, Genetic